BNP Paribas Financial Markets’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2K | Buy |
9,413
+4,134
| +78% | +$13.7K | ﹤0.01% | 3610 |
|
|
2025
Q1 | $15.3K | Sell |
5,279
-6,261
| -54% | -$18.2K | ﹤0.01% | 3772 |
|
|
2024
Q4 | $41.1K | Sell |
11,540
-7,286
| -39% | -$25.9K | ﹤0.01% | 3656 |
|
|
2024
Q3 | $93.8K | Buy |
18,826
+13,481
| +252% | +$67.1K | ﹤0.01% | 2753 |
|
|
2024
Q2 | $13.9K | Buy |
5,345
+5,344
| +534,400% | +$13.9K | ﹤0.01% | 3012 |
|
|
2024
Q1 | $4 | Hold |
1
| – | – | ﹤0.01% | 3346 |
|
|
2023
Q4 | $2 | Hold |
1
| – | – | ﹤0.01% | 3279 |
|
|
2023
Q3 | $2 | Buy |
+1
| New | +$2 | ﹤0.01% | 3224 |
|
|
2022
Q3 | – | Sell |
-1,136
| Closed | -$727 | – | 4019 |
|
|
2022
Q2 | $727 | Sell |
1,136
-33,674
| -97% | -$21.6K | ﹤0.01% | 3289 |
|
|
2022
Q1 | $90.9K | Buy |
34,810
+18,860
| +118% | +$49.2K | ﹤0.01% | 2817 |
|
|
2021
Q4 | $62K | Buy |
15,950
+15,833
| +13,532% | +$61.6K | ﹤0.01% | 3059 |
|
|
2021
Q3 | $510 | Sell |
117
-104
| -47% | -$453 | ﹤0.01% | 3319 |
|
|
2021
Q2 | $877 | Sell |
221
-2,274
| -91% | -$9.02K | ﹤0.01% | 3354 |
|
|
2021
Q1 | $13K | Sell |
2,495
-868
| -26% | -$4.51K | ﹤0.01% | 3238 |
|
|
2020
Q4 | $18K | Sell |
3,363
-887
| -21% | -$4.75K | ﹤0.01% | 3204 |
|
|
2020
Q3 | $20.6K | Buy |
4,250
+3,506
| +471% | +$17K | ﹤0.01% | 3198 |
|
|
2020
Q2 | $3.62K | Buy |
744
+699
| +1,553% | +$3.4K | ﹤0.01% | 3476 |
|
|
2020
Q1 | $99 | Hold |
45
| – | – | ﹤0.01% | 3599 |
|
|
2019
Q4 | $262 | Sell |
45
-1,354
| -97% | -$7.88K | ﹤0.01% | 3623 |
|
|
2019
Q3 | $4.45K | Hold |
1,399
| – | – | ﹤0.01% | 3640 |
|
|
2019
Q2 | $5.88K | Sell |
1,399
-1,090
| -44% | -$4.58K | ﹤0.01% | 3591 |
|
|
2019
Q1 | $17.2K | Buy |
+2,489
| New | +$17.2K | ﹤0.01% | 3345 |
|